We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Progressive Goal Attainment Program for Veterans (PGAP for Vets)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01565863
Recruitment Status : Unknown
Verified March 2012 by MDRC.
Recruitment status was:  Recruiting
First Posted : March 29, 2012
Last Update Posted : March 29, 2012
Sponsor:
Collaborators:
VA Connecticut Healthcare System
Michael Debakey Veterans Affairs Medical Center
The Boeing Company
Bristol-Myers Squibb
The Community Foundation for Greater New Haven
Disabled American Veterans
Information provided by (Responsible Party):
MDRC

Brief Summary:
The purpose of this study is to test the effectiveness of the Progressive Goal Attainment Program (PGAP) in improving employment outcomes and community engagement among U.S. veterans with disabilities.

Condition or disease Intervention/treatment Phase
Mental Disorders Worries; Pain or Disability Behavioral: Progressive Goal Attainment Program Phase 1

Detailed Description:
Veterans with disabilities often have low self-esteem and motivation, significant depression and a belief that their disability precludes them from gainful employment. The Progressive Goal Attainment Program (PGAP) is specifically designed to target these psycho-social risk factors of disability. PGAP is a structured, 10-week intervention that focuses on helping clients develop a planned activity schedule to assist them in resuming desirable life activities, including employment. The PGAP for Veterans Project will test the feasibility of delivering PGAP to U.S. military veterans. The research will focus on the best means of service delivery, staffing needs and how to coordinate PGAP in a larger veteran service system. MDRC will also gather information on the target population, recruitment methods, the feasibility of scaling and replication, and employment outcomes among the sample. Two hundred veterans will be enrolled and randomly assigned into the study across two sites: Errera Community Care Center within (part of the VA Connecticut Health Care System) and the Michael DeBakey VA Medical Center in Houston, Texas.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: The Progressive Goal Attainment Program for Veterans Project
Study Start Date : February 2012
Estimated Primary Completion Date : June 2013
Estimated Study Completion Date : June 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Progressive Goal Attainment Program Behavioral: Progressive Goal Attainment Program
The Progressive Goal Attainment Program (PGAP) is a behavioral intervention originally developed in Canada at McGill University in order to increase return to work and community integration for individuals who receive worker's compensation. PGAP is the first disability program that is specifically designed to target the psycho-social risk factors of disability. The premise behind PGAP is that inactivity and attitudinal barriers increase work disability, and these issues are a primary cause of unemployment for individuals with physical and mental disabilities. PGAP is a structured, 10-week intervention that focuses upon helping clients develop a planned activity schedule to assist them in resuming desirable life activities.
Other Name: PGAP
No Intervention: VA employment services



Primary Outcome Measures :
  1. Employment [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Quality of Life [ Time Frame: 6 months ]
    Lehman Quality of Life Interview: Participants to rate their level of satisfaction with several domains of their lives (e.g. daily activities, social relations etc.) and their feelings about their lives as a whole on a 1-7 ("delighted" to "terrible") scale.

  2. Citizenship [ Time Frame: 6 months ]
    Citizenship Measure: 42-item scale that asks about the person's involvement in community and social activities and their ability to act and make choices on their own behalf on a 1-5 ("not at all/never" to "a lot/very often") scale



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Self-reporting a disability.
  • Unemployed or under-employed.
  • Likely to benefit from PGAP (i.e. unengaged in social and community activities, difficulty attaining work due to motivational factors).

Exclusion Criteria:

  • Does not consent to be in the study.
  • Significant barriers: serious substance abuse, significant psychotic disorders and cognitive disabilities that would preclude them from active participation in PGAP.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01565863


Contacts
Contact: Peter Baird 212-340-8834 peter.baird@mdrc.org

Locations
United States, Connecticut
VA Connecticut Health Care Center Recruiting
West Haven, Connecticut, United States, 06516
Contact: Jack Tsai, PhD    203-932-5711 ext 2090    jack.tsai@yale.edu   
Principal Investigator: Jack Tsai, PhD         
United States, Texas
Michael E. DeBakey VA Medical Center Not yet recruiting
Houston, Texas, United States, 77030
Contact: Anthony Kerrigan, PhD    713-794-7703    kerrigan.anthonyj@va.gov   
Contact: Daisy Courtade, MS    713-791-1414 ext 4233    Daisy.Courtade@va.gov   
Principal Investigator: Anthony Kerrigan, PhD         
Sponsors and Collaborators
MDRC
VA Connecticut Healthcare System
Michael Debakey Veterans Affairs Medical Center
The Boeing Company
Bristol-Myers Squibb
The Community Foundation for Greater New Haven
Disabled American Veterans
Investigators
Study Director: Peter Baird MDRC
Principal Investigator: Jack Tsai VA Connecticut Healthcare System
Principal Investigator: Anthony Kerrigan Michael DeBakey VA Medical Center